An EORTC phase I study of capecitabine (Xeloda(R)) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer

By Bonnefoi H.   Biganzoli L.   Mauriac L.   Cufer T.   Schaefer P.   Atalay G.   Piccart M.  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1277-1283

Elsevier

Access to resources Recommend Favorite

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer

By Bonnefoi H.  

Breast Cancer Research and Treatment, Vol. 70, Iss. 1, 2001-11 ,pp. : 55-63

Springer Publishing Company

Access to resources Recommend Favorite

Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer

By Torrisi Rosalba  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 431-441

Springer Publishing Company

Access to resources Recommend Favorite

Locally advanced primary breast cancer - medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy

By Tan S.M.   Cheung K.L.   Willsher P.C.   Blamey R.W.   Chan S.Y.   Robertson J.F.R.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2331-2338

Elsevier

Access to resources Recommend Favorite

Primary endocrine therapy in locally advanced breast cancers—the Nottingham experience

By Mathew J.  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 403-407

Springer Publishing Company

Access to resources Recommend Favorite